PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Drug ReportsLevocarnitine
Levocarnitine
Carnitor, Levocarnitine (levocarnitine) is a small molecule pharmaceutical. Levocarnitine was first approved as Carnitor on 1985-12-27. It is used to treat deficiency diseases in the USA.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
nutritional and metabolic diseasesD009750
Trade Name
FDA
EMA
Carnitor, Carnitor sf, Levocarnitine, Levocarnitine sf (discontinued: Carnitor, Levocarnitine)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Levocarnitine
Tradename
Company
Number
Date
Products
CARNITORLeadiant BiosciencesN-018948 RX1985-12-27
1 products, RLD, RS
CARNITORLeadiant BiosciencesN-020182 RX1992-12-16
1 products, RLD, RS
CARNITORLeadiant BiosciencesN-019257 RX1986-04-10
1 products, RLD, RS
CARNITOR SFLeadiant BiosciencesN-019257 RX2007-03-28
1 products, RLD
Show 1 discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
carnitorNew Drug Application2024-10-30
carnitor sfNew Drug Application2024-11-04
levocarnitineANDA2024-12-27
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
deficiency diseasesEFO_1001067D003677E63
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
A: Alimentary tract and metabolism drugs
— A16: Other alimentary tract and metabolism products in atc
— A16A: Other alimentary tract and metabolism products in atc
— A16AA: Amino acids and derivatives
— A16AA01: Levocarnitine
HCPCS
Code
Description
J1955
Injection, levocarnitine, per 1 gm
Clinical
No data
Drug
General
Drug common nameLevocarnitine
INNlevocarnitine
Description
Carnitine is an amino-acid betaine that is butanoate substituted with a hydroxy group at position C-3 and a trimethylammonium group at C-4. It has a role as a human metabolite and a mouse metabolite. It is functionally related to a butyrate. It is a conjugate base of a carnitinium.
Classification
Small molecule
Drug class—
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
C[N+](C)(C)C[C@H](O)CC(=O)[O-]
Identifiers
PDB—
CAS-ID541-15-1
RxCUI—
ChEMBL IDCHEMBL1149
ChEBI ID16347
PubChem CID288
DrugBankDB00583
UNII ID0G389FZZ9M (ChemIDplus, GSRS)
Target
No data
Variants
No data
Financial
Revenue by drug
$
€
£
₣
No data
Estimated US medical usage
Levocarnitine
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Tabular view
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
0 adverse events reported
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use